cTRL Therapeutics

Developer of a microfluidic cell therapy intended to treat cancerous tumors. The company's therapy uses proprietary cell-sorting technology to isolate and extract tumor-reactive lymphocytes from blood, preserving cell viability and functionality, enabling healthcare providers to develop non-invasive, efficient, and scalable cancer treatments.

General Catalyst

🏥 Healthcare